Document is current

Article History

Received: 3 July 2025

Accepted: 20 September 2025

First Online: 27 November 2025

Declarations

:

: All participants gave written informed consent prior to study participation.

: Not applicable.

: CA has served as a consultant for Lilly, Novartis, and Teva and has received honoraria from AbbVie, Amgen, Lilly, Novartis, Teva, and Theranica; he has received royalties from Elsevier for Pain Management Secrets and Raj’s Practical Management of Pain. FAK has received institutional research support from Biohaven, Teva, Marinus, Lundbeck, Supernus, Neurona, and UCB; advisory fees from Eisai, Neurelis, Marinus, Epitel, SK Life Science, AbbVie, Pfizer; honorarium for speaker engagements from Amgen, UCB, SK Life Science, Lundbeck, Allergan, Lilly USA, Pfizer, Impel Pharmaceuticals, AbbVie; honorarium for educational programs from Natus and Stratus; has served on the Louisiana State Medical Advisory Board in a non-paid position and on the board of directors for Deccan Alumni Association of North America in a non-paid position. SPH reports receiving honoraria for speaker engagements from AbbVie. RMS reports no conflicts. DCB has received grant support from Amgen, the US Food and Drug Administration, and the National Headache Foundation; has served as a consultant and received honoraria from Allergan/AbbVie, Amgen/Novartis, Biohaven, Collegium, Eli Lilly, Lundbeck, Pfizer, Theranica, and Teva; and has served on the editorial board of Current Pain and Headache Reports. SSB, DA, SFA, SWG, and FP are full-time employees of Lundbeck LLC or H. Lundbeck A/S.